Selective Focus and Concentration in the BPO Outsourcing Business
First written in FY2016. 19 of 31 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-08-07.
The whole theme swung hardest in 2022: 3 of 17 companies on the "Worse" side.
6 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「As a result, revenue was ¥14,300 million, up 5.1% year on year, and operating profit was ¥1,898 million, up 11.3%.」
For the full year, the BPO business generated revenue of ¥14,300 million and operating profit of ¥1,898 million, resulting in higher revenue and operating profit year on year. - 2026-05-14AdvancedEarnings
「We are expanding the scale of our CSO, CRO, recruitment and temporary staffing, and publishing-related businesses.」
The expansion of the 4 main BPO businesses continues. - FY2026-H1AdvancedAnnual report
「In the BPO business, we will continue expanding the scale of our CSO, CRO, placement and temporary staffing, and publishing-related operations. As a result, revenue was ¥7,053 million, up 4.4% year on year, and operating profit was ¥1,002 million, up 8.0%.」
The scale of the CSO, CRO, placement and temporary staffing, and publishing-related businesses continued to expand, resulting in higher revenue and operating profit in the BPO business. - FY2025-H1AdvancedAnnual report
「As a result, revenue was ¥6,755 million, up 1.2% year on year, and operating profit was ¥928 million, up 15.9%.」
The BPO business generated revenue of ¥6,755 million and operating profit of ¥928 million during the interim consolidated accounting period, resulting in higher revenue and operating profit year on year. The business continues to expand the scale of its CSO, placement and temporary staffing, and publishing-related operations. - FY2024Full-year higher revenue but lower operating profit in the healthcare-related businessAnnual report
「As a result, revenue was ¥14,952 million, up 2.0% year on year, and operating profit was ¥1,136 million, down 25.9%.」
The healthcare-related business recorded higher full-year revenue, while operating profit declined 25.9% year on year, resulting in higher revenue but lower operating profit. - FY2024-Q3Healthcare-Related Business: Higher Revenue, Lower ProfitAnnual report
「In the healthcare-related business, we will continue working to expand our core CSO, placement and temporary staffing, publishing-related, and pharmaceutical manufacturing and sales businesses, while pursuing steady growth to advance toward becoming a comprehensive healthcare company. As a result, revenue was ¥11,274 million, up 4.3% year on year, and operating profit was ¥884 million, down 23.6%.」
While continuing to pursue the expansion of the CSO, placement and temporary staffing, publishing, and pharmaceutical manufacturing and sales businesses, the healthcare-related business recorded higher revenue but lower operating profit. - FY2023-Q3AdvancedAnnual report
「As a result, revenue was ¥10,814 million, up 12.0% year on year, and operating profit was ¥1,158 million, up 24.5%.」
The healthcare-related business generated revenue of ¥10,814 million and operating profit of ¥1,158 million, resulting in higher revenue and operating profit year on year. - FY2023-Q2Healthcare-Related Business: Higher Revenue, Lower ProfitAnnual report
「In the healthcare-related business, we will continue working to expand our core CSO, placement and temporary staffing, publishing-related, and pharmaceutical manufacturing and sales businesses, while building a stable foundation for advancing toward becoming a comprehensive healthcare company.」
The policy of continuing to expand the CSO, placement and temporary staffing, publishing-related, and pharmaceutical manufacturing and sales businesses was maintained. Revenue in the healthcare-related business was ¥6,901 million, up 6.6% year on year, while operating profit was ¥645 million, down 2.6%. - FY2023-Q1AdvancedAnnual report
「In the healthcare-related business, we will continue working to expand our core CSO, placement and temporary staffing, pharmaceutical manufacturing and sales, and publishing-related businesses, while building a stable foundation for advancing toward becoming a comprehensive healthcare company. As a result, revenue was ¥3,392 million, up 6.9% year on year, and operating profit was ¥349 million, up 12.3%.」
The CSO, placement and temporary staffing, pharmaceutical manufacturing and sales, and publishing-related businesses were expanded, resulting in higher revenue and operating profit in the healthcare-related business, at ¥3,392 million and ¥349 million, respectively. - FY2022Healthcare-related business: full-year decline in revenue and operating profitAnnual report
「As a result, revenue was ¥13,094 million, down 0.1% year on year, and operating profit was ¥1,190 million, down 19.4%.」
For the full year, the healthcare-related business generated revenue of ¥13,094 million and operating profit of ¥1,190 million, resulting in lower revenue and operating profit year on year. - FY2022-Q3Healthcare-related business: lower revenue and operating profitAnnual report
「In the pharmaceutical manufacturing and sales business, sales from joint promotions with major partner pharmaceutical companies have remained strong. In addition to continuing to promote sales of its own products, the company is preparing to update its manufacturing execution system, which visualizes manufacturing processes and provides instructions and support to workers. As a result, revenue was ¥9,655 million, down 2.7% year on year, and operating profit was ¥930 million, down 25.1%.」
Although sales from joint promotions in the healthcare-related business remained strong, cumulative revenue was ¥9,655 million and operating profit was ¥930 million, representing year-on-year declines in both revenue and profit. - FY2021AdvancedAnnual report
「In the healthcare-related business, the CSO business and pharmaceutical manufacturing and sales business progressed steadily. By expanding the healthcare-related business, a growth area, the company will increase its share of operating profit and build a stable foundation for advancing toward becoming a comprehensive healthcare company. As a result, revenue was ¥13,109 million, up 7.2% year on year, and operating profit was ¥1,350 million, up 0.4%.」
The healthcare-related business, including BPO, recorded revenue of ¥13,109 million and operating profit of ¥1,350 million. The company indicated a policy of expanding it as a growth area and increasing its share of operating profit. - FY2021-Q3AdvancedAnnual report
「As a result, revenue was ¥9,923 million, up 11.8% year on year, and operating profit was ¥1,148 million, up 10.5%.」
For the cumulative third quarter, the healthcare-related business recorded revenue of ¥9,923 million and operating profit of ¥1,148 million, representing year-on-year increases in both revenue and profit. - FY2021-Q2AdvancedAnnual report
「As a result, revenue increased by ¥1,144 million year on year to ¥6,754 million, up 20.4%, and operating profit increased by ¥144 million to ¥871 million, up 19.8%.」
For the cumulative second quarter, the healthcare-related business recorded revenue of ¥6,754 million and operating profit of ¥871 million, representing year-on-year increases in both revenue and profit. - FY2020-Q3AdvancedAnnual report
「As a result, revenue increased by ¥900 million year on year to ¥8,876 million, up 11.3%, and operating profit increased by ¥105 million to ¥1,038 million, up 11.3%.」
For the cumulative third quarter, the BPO business recorded revenue of ¥8,876 million and operating profit of ¥1,038 million, representing year-on-year increases in both revenue and profit. - FY2020-Q2AdvancedAnnual report
「In the highly profitable BPO business, the company is expanding earnings and working to optimize its portfolio by strengthening sales capabilities and improving productivity. As a result, revenue increased by ¥323 million year on year to ¥5,609 million, up 6.1%, and operating profit increased by ¥69 million to ¥727 million, up 10.6%.」
The company expanded BPO earnings by strengthening sales capabilities and improving productivity, recording cumulative revenue of ¥5,609 million and operating profit of ¥727 million. - FY2020-Q1AdvancedAnnual report
「In the highly profitable BPO business, the Group’s second pillar, the company is expanding earnings and working to optimize its portfolio by strengthening sales capabilities and improving productivity.」
The company is expanding BPO earnings and optimizing its portfolio by strengthening sales capabilities and improving productivity, resulting in revenue of ¥2,800 million and operating profit of ¥431 million. - FY2019AdvancedAnnual report
「In the highly profitable BPO business, the company is expanding earnings and working to optimize its portfolio by strengthening sales capabilities and improving productivity, mainly in the recruitment and temporary staffing and CRO businesses. As a result, revenue increased by ¥229 million year on year to ¥10,660 million, up 2.2%, and operating profit increased by ¥24 million to ¥1,366 million, up 1.8%.」
By strengthening sales capabilities and improving productivity, mainly in the recruitment and temporary staffing and CRO businesses, the BPO business recorded revenue of ¥10,660 million and operating profit of ¥1,366 million. - FY2019-Q3RestatedAnnual report
「In the highly profitable BPO business, the Group’s second pillar, the company is expanding earnings and working to optimize its portfolio.」
The company continues to expand earnings and optimize its portfolio with the health-insurance pharmacy business, positioning the BPO business as its second pillar. - FY2019-Q2ReframedAnnual report
「In the highly profitable BPO business, the Group’s second pillar, the company is expanding earnings and working to optimize its portfolio.」
Although the wording changed from “BPO contract business” to “BPO business,” the company continues to expand earnings and optimize its portfolio as its second pillar. - FY2019-Q1RestatedAnnual report
「In the highly profitable BPO contract business, the Group’s second pillar, the company is expanding earnings and working to optimize its portfolio.」
The company continues its policy of expanding earnings and optimizing its portfolio with the health-insurance pharmacy business, positioning the BPO contract business as its second pillar. - FY2018-Q3RestatedAnnual report
「The company is expanding earnings in the highly profitable, high-growth BPO contract business, its second pillar, and working to optimize its portfolio with the health-insurance pharmacy business.」
The company positions the BPO contract business as its second pillar and continues to expand earnings and optimize its portfolio with the health-insurance pharmacy business. In the cumulative period through the current quarter, however, the BPO contract business recorded lower revenue and operating profit. - FY2018-Q2RestatedAnnual report
「The company is expanding earnings in the highly profitable, high-growth BPO contract business, its second pillar, and working to optimize its portfolio with the health-insurance pharmacy business.」
The company positions the BPO contract business as its second pillar and continues to expand earnings and optimize its portfolio with the health-insurance pharmacy business. - FY2018-Q1RestatedAnnual report
「The BPO contract business, the Group’s second pillar, is a highly profitable, high-growth business area. The company is pursuing further earnings growth to optimize its portfolio with the health-insurance pharmacy business.」
The company positions the BPO contract business as its second earnings pillar and continues to optimize its portfolio with the health-insurance pharmacy business while expanding earnings. - FY2017AdvancedAnnual report
「As a result, revenue increased by ¥1,256 million year on year to ¥10,905 million, up 13.0%, and operating profit increased by ¥498 million to ¥1,498 million, up 49.8%.」
For the full year, the BPO contract business recorded revenue of ¥10,905 million and operating profit of ¥1,498 million, representing year-on-year increases in both revenue and profit. - FY2017-Q3AdvancedAnnual report
「In the cumulative third quarter of the current consolidated fiscal period, the thorough profit and loss management and business selection and concentration pursued in the previous fiscal year contributed to results. The CSO business continued to grow steadily, and results progressed steadily together with the strong recruitment and temporary staffing business. As a result, revenue increased by ¥1,210 million year on year to ¥8,208 million, up 17.3%, and operating profit increased by ¥375 million to ¥1,154 million, up 48.1%.」
The effects of profit and loss management and business selection and concentration continued, with the BPO contract business expanding to revenue of ¥8,208 million and operating profit of ¥1,154 million. - FY2017-Q2AdvancedAnnual report
「In the cumulative second quarter of the current consolidated fiscal period, the thorough profit and loss management and business selection and concentration pursued in the previous fiscal year contributed to results. In the CSO business, the company is working to increase market share by adding operating personnel, and results have progressed steadily together with the strong recruitment and temporary staffing business. As a result, revenue increased by ¥884 million year on year to ¥5,492 million, up 19.2%, and operating profit increased by ¥266 million to ¥791 million, up 50.8%.」
In addition to the effects of profit and loss management and selection and concentration, increased operating personnel in the CSO business drove revenue to ¥5,492 million and operating profit to ¥791 million. - FY2017-Q1AdvancedAnnual report
「The thorough profit and loss management and business selection and concentration pursued in the previous fiscal year contributed to results. In the CSO business, the company is working to increase market share by adding operating personnel, and results have progressed steadily together with the strong recruitment and temporary staffing business. As a result, revenue increased by ¥492 million year on year to ¥2,767 million, up 21.7%, and operating profit increased by ¥169 million to ¥459 million, up 58.4%.」
The effects of profit and loss management and business selection and concentration were reflected in results, with revenue and operating profit from the BPO contract business increasing year on year. - FY2016First statedAnnual report
「The company will promote growth through selective focus and concentration in the BPO contract business.」
A policy of promoting growth through selective focus and concentration in the BPO business.